A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)

NCT02365441 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

78

Enrollment

NETWORK

Sponsor class

Conditions

Gastrointestinal Stromal Tumour

Interventions

DRUG: Regorafenib
DRUG: imatinib

Sponsor

Australasian Gastro-Intestinal Trials Group

Collaborators

[object Object]
[object Object]